Thrita

Published by: Kowsar

Evaluation of the Protective Effect of Brassica oleracea (L. var. acephala) in Rats with Surgically-Induced Gastroesophageal Reflux Disease

Fernanda Wisnieski 1 , * , Pedro Luiz Brito 2 , Stella Regina Villarinho Naddeo Cosenza 1 , Perseu Artemus Duarte Pinto 3 , Isabela Cristina Simoni 4 , Maria Judite Bittencourt Fernandes 4 , Maxuel Andrade 5 , Deborah Yara Alves Cursino Santos 5 , Sérgio Tomaz Schettini 2 , Marília Cardoso Smith 1 , Luís Fernando Barbisan 6 , Sandra Aparecida Takahashi Hyodo 3 and Dertia Villalba Freire Maia 1
Authors Information
1 Departamento de Morfologia e Genética, Disciplina de Genética, Universidade Federal de São Paulo, São Paulo, Brazil
2 Departamento de Cirurgia Pediátrica, Universidade Federal de São Paulo, São Paulo, Brazil
3 Área da Saúde, Universidade Braz Cubas, Mogi das Cruzes, São Paulo, Brazil
4 Centro de P and D de Sanidade Animal, Instituto Biológico/ APPA-SAA, São Paulo, Brazil
5 Departamento de Botânica, Instituto de Biociências, Universidade de São Paulo, São Paulo, Brazil
6 Departamento de Morfologia, Instituto de Biociências, Universidade Estadual Paulista, Botucatu, São Paulo, Brazil
Article information
  • Thrita: September 01, 2016, 5 (3); e34363
  • Published Online: July 25, 2016
  • Article Type: Research Article
  • Received: November 5, 2015
  • Revised: May 17, 2016
  • Accepted: June 16, 2016
  • DOI: 10.5812/thrita.34363

To Cite: Wisnieski F, Brito P L, Villarinho Naddeo Cosenza S R, Duarte Pinto P A, Simoni I C, et al. Evaluation of the Protective Effect of Brassica oleracea (L. var. acephala) in Rats with Surgically-Induced Gastroesophageal Reflux Disease, Thrita. 2016 ;5(3):e34363. doi: 10.5812/thrita.34363.

Abstract
Copyright © 2016, Thrita. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnote
References
  • 1. Pandolfino JE, Kwiatek MA, Kahrilas PJ. The pathophysiologic basis for epidemiologic trends in gastroesophageal reflux disease. Gastroenterol Clin North Am. 2008; 37(4): 827-43[DOI][PubMed]
  • 2. Altomare A, Guarino MP, Cocca S, Emerenziani S, Cicala M. Gastroesophageal reflux disease: Update on inflammation and symptom perception. World J Gastroenterol. 2013; 19(39): 6523-8[DOI][PubMed]
  • 3. Nasi A, de Moraes-Filho JP, Cecconello I. [Gastroesophageal reflux disease: an overview]. Arq Gastroenterol. 2006; 43(4): 334-41[PubMed]
  • 4. Isomoto H, Nishi Y, Kanazawa Y, Shikuwa S, Mizuta Y, Inoue K, et al. Immune and Inflammatory Responses in GERD and Lansoprazole. J Clin Biochem Nutr. 2007; 41(2): 84-91[DOI][PubMed]
  • 5. Kawanishi S, Hiraku Y. Oxidative and nitrative DNA damage as biomarker for carcinogenesis with special reference to inflammation. Antioxid Redox Signal. 2006; 8(5-6): 1047-58[DOI][PubMed]
  • 6. Kang SH, Kwon JY, Lee JK, Seo YR. Recent advances in in vivo genotoxicity testing: prediction of carcinogenic potential using comet and micronucleus assay in animal models. J Cancer Prev. 2013; 18(4): 277-88[PubMed]
  • 7. Numans ME, Lau J, de Wit NJ, Bonis PA. Short-term treatment with proton-pump inhibitors as a test for gastroesophageal reflux disease: a meta-analysis of diagnostic test characteristics. Ann Intern Med. 2004; 140(7): 518-27[PubMed]
  • 8. Yang XG, Zhang GH, Li W, Peng B, Liu ZD, Pan WS. Design and evaluation of jingzhiguanxin monolithic osmotic pump tablet. Chem Pharm Bull (Tokyo). 2006; 54(4): 465-9[PubMed]
  • 9. Canani RB, Cirillo P, Roggero P, Romano C, Malamisura B, Terrin G, et al. Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children. Pediatrics. 2006; 117(5): 817-20[DOI][PubMed]
  • 10. Ho E, Clarke JD, Dashwood RH. Dietary sulforaphane, a histone deacetylase inhibitor for cancer prevention. J Nutr. 2009; 139(12): 2393-6[DOI][PubMed]
  • 11. Fimognari C, Hrelia P. Sulforaphane as a promising molecule for fighting cancer. Mutat Res. 2007; 635(2-3): 90-104[DOI][PubMed]
  • 12. Zhu CY, Loft S. Effect of chemopreventive compounds from Brassica vegetables on NAD(P)H:quinone reductase and induction of DNA strand breaks in murine hepa1c1c7 cells. Food Chem Toxicol. 2003; 41(4): 455-62[PubMed]
  • 13. Silva MS, Antoniolli AR, Batista JS, Mota CN. Plantas medicinais usadas nos distúrbios do trato gastrointestinal no povoado ColôniaTreze, Lagarto, SE, Brasil. Acta Botanica Brasilica. 2006; 20: 815-29
  • 14. Sorensen M, Jensen BR, Poulsen HE, Deng X, Tygstrup N, Dalhoff K, et al. Effects of a Brussels sprouts extract on oxidative DNA damage and metabolising enzymes in rat liver. Food Chem Toxicol. 2001; 39(6): 533-40[PubMed]
  • 15. Simoni IC, Munford V, Felicio JD, Lins AP. Antiviral activity of crude extracts of Guarea guidona. Braz J Med Biol Res. 1996; 29(5): 647-50[PubMed]
  • 16. Garber J, Wayne Barbee R, Bielitzki JT, Donovan JC, Hendriksen CFM, Kohn DF, et al. Guide for the Care and Use of Laboratory Animals. 1985;
  • 17. Melo LL, Kruel CD, Kliemann LM, Cavazzola LT, Boeno Rda L, Silber PC, et al. Influence of surgically induced gastric and gastroduodenal content reflux on esophageal carcinogenesis--experimental model in Wistar female rats. Dis Esophagus. 1999; 12(2): 106-15[PubMed]
  • 18. Schmid W. The micronucleus test. Mutat Res. 1975; 31(1): 9-15[PubMed]
  • 19. Miwa K, Sahara H, Segawa M, Kinami S, Sato T, Miyazaki I, et al. Reflux of duodenal or gastro-duodenal contents induces esophageal carcinoma in rats. Int J Cancer. 1996; 67(2): 269-74[DOI][PubMed]
  • 20. Zhang T, Zhang F, Han Y, Gu Z, Zhou Y, Cheng Q, et al. A rat surgical model of esophageal metaplasia and adenocarcinoma-induced by mixed reflux of gastric acid and duodenal contents. Dig Dis Sci. 2007; 52(11): 3202-8[DOI][PubMed]
  • 21. Khor TO, Yu S, Kong AN. Dietary cancer chemopreventive agents - targeting inflammation and Nrf2 signaling pathway. Planta Med. 2008; 74(13): 1540-7[DOI][PubMed]
  • 22. Fahey JW, Haristoy X, Dolan PM, Kensler TW, Scholtus I, Stephenson KK, et al. Sulforaphane inhibits extracellular, intracellular, and antibiotic-resistant strains of Helicobacter pylori and prevents benzo[a]pyrene-induced stomach tumors. Proc Natl Acad Sci U S A. 2002; 99(11): 7610-5[DOI][PubMed]
  • 23. Yanaka A, Fahey JW, Fukumoto A, Nakayama M, Inoue S, Zhang S, et al. Dietary sulforaphane-rich broccoli sprouts reduce colonization and attenuate gastritis in Helicobacter pylori-infected mice and humans. Cancer Prev Res (Phila). 2009; 2(4): 353-60[DOI][PubMed]
  • 24. Dickinson SE, Melton TF, Olson ER, Zhang J, Saboda K, Bowden GT. Inhibition of activator protein-1 by sulforaphane involves interaction with cysteine in the cFos DNA-binding domain: implications for chemoprevention of UVB-induced skin cancer. Cancer Res. 2009; 69(17): 7103-10[DOI][PubMed]
  • 25. Saw CL, Huang MT, Liu Y, Khor TO, Conney AH, Kong AN. Impact of Nrf2 on UVB-induced skin inflammation/photoprotection and photoprotective effect of sulforaphane. Mol Carcinog. 2011; 50(6): 479-86[DOI][PubMed]
  • 26. Haristoy X, Angioi-Duprez K, Duprez A, Lozniewski A. Efficacy of sulforaphane in eradicating Helicobacter pylori in human gastric xenografts implanted in nude mice. Antimicrob Agents Chemother. 2003; 47(12): 3982-4[PubMed]
  • 27. Shen G, Khor TO, Hu R, Yu S, Nair S, Ho CT, et al. Chemoprevention of familial adenomatous polyposis by natural dietary compounds sulforaphane and dibenzoylmethane alone and in combination in ApcMin/+ mouse. Cancer Res. 2007; 67(20): 9937-44[DOI][PubMed]
  • 28. Fimognari C, Lenzi M, Sestili P, Turrini E, Ferruzzi L, Hrelia P, et al. Sulforaphane potentiates RNA damage induced by different xenobiotics. PLoS One. 2012; 7(4): 35267[DOI][PubMed]
  • 29. Kedika RR, Souza RF, Spechler SJ. Potential anti-inflammatory effects of proton pump inhibitors: a review and discussion of the clinical implications. Dig Dis Sci. 2009; 54(11): 2312-7[DOI][PubMed]
  • 30. Handa O, Yoshida N, Fujita N, Tanaka Y, Ueda M, Takagi T, et al. Molecular mechanisms involved in anti-inflammatory effects of proton pump inhibitors. Inflamm Res. 2006; 55(11): 476-80[DOI][PubMed]
  • 31. Suzuki M, Mori M, Miura S, Suematsu M, Fukumura D, Kimura H, et al. Omeprazole attenuates oxygen-derived free radical production from human neutrophils. Free Radic Biol Med. 1996; 21(5): 727-31[PubMed]
  • 32. Sinues B, Fanlo A, Bernal ML, Val M Mayayo E. Omeprazole treatment: genotoxicity biomarkers, and potential to induce CYP1A2 activity in humans. Human Experimentl Toxicol. 2004; 23: 107-13
  • 33. Phillips DH, Hewer A, Osborne MR. Interaction of omeprazole with DNA in rat tissues. Mutagenesis. 1992; 7(4): 277-83[PubMed]
  • 34. Suzuki M, Suzuki H, Hibi T. Proton pump inhibitors and gastritis. J Clin Biochem Nutr. 2008; 42(2): 71-5[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments